-+ 0.00%
-+ 0.00%
-+ 0.00%

United Laboratories Wins China Approval for UBT48128 Obesity Drug Trial

PUBT·11/19/2026 13:56:33
Listen to the news
United Laboratories Wins China Approval for UBT48128 Obesity Drug Trial
  • United Laboratories received Chinese regulatory clearance to begin clinical trials of UBT48128 tablets for overweight or obesity.
  • The once-daily oral GLP-1 drug received FDA clearance for its investigational new drug application on August 11, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261119-12419223), on November 19, 2026, and is solely responsible for the information contained therein.